Artículos por temáticas

Effectiveness of Telemedicine Interventions on Motor and Nonmotor Outcomes in Parkinson Disease: Systematic Review and Network Meta-Analysis

Dou J, Wang J, Gao X, Wang G, Bai Y, Liang Y, Yang K, Yang Y, Zhang L.

J Med Internet Res. 2025 Jun 3;27:e71169. doi: 10.2196/71169.

"Methyl jasmonate: bridging plant defense mechanisms and human therapeutics"

Sharma G, Badruddeen, Akhtar J, Khan MI, Ahmad M, Sharma PK.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):6429-6451. doi: 10.1007/s00210-024-03752-x. Epub 2025 Jan 23.

Bowing Index in Individuals With Parkinson's Disease, Progressive Supranuclear Palsy, and Ataxia

Tipton CB, Borders JC, Curtis JA, Troche MS.

Laryngoscope. 2025 Jun;135(6):2081-2085. doi: 10.1002/lary.31993. Epub 2025 Feb 2.

Interrelationship between PQ exposure and Parkinson disease: A systematic review and meta-analysis

Ba RQ, Fan XJ, Fan HJ, Du K, Ma X, Wen Y, Liu MW.

Medicine (Baltimore). 2025 Jun 13;104(24):e42796. doi: 10.1097/MD.0000000000042796.

Association between chemokine genes polymorphisms and susceptibility to Parkinson's disease: a meta-analysis and systematic review

Lee YH, Song GG.

Acta Neurol Belg. 2025 Jun;125(3):599-607. doi: 10.1007/s13760-024-02615-9. Epub 2024 Jul 27.

Current trends and future prospects of N-acetylcysteine utilizations in Parkinson's disease: A literature network analysis

Muthmainah M, Wiyono N, Syah FK, Purnianto A, Yudhani RD, Wasita B.

J Taibah Univ Med Sci. 2025 May 29;20(3):298-306. doi: 10.1016/j.jtumed.2025.05.004. eCollection 2025 Jun.

Long-term Neurological Consequences of COVID-19 in Patients With Pre-existing Alzheimer's and Parkinson's Disease: A Comprehensive Review

Elechi KW, Oyepeju Nkem O, Timothy Chibueze N, Elechi US, Franklin Chimaobi K.

Neurosci Insights. 2025 May 29;20:26331055251342755. doi: 10.1177/26331055251342755. eCollection 2025.

Intersection of H(2)S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases

Soni P, Paswan S, Paul BD, Thomas B.

Neurotherapeutics. 2025 Jun 21:e00627. doi: 10.1016/j.neurot.2025.e00627. Online ahead of print.

Research progress of platelets in neurodegenerative diseases

Lan Y, Ding J, Yu T, Cheng C.

Front Aging Neurosci. 2025 Jun 10;17:1544605. doi: 10.3389/fnagi.2025.1544605. eCollection 2025.

Neuroinflammation in chronic pain: Myth or reality?

Butler SH.

Scand J Pain. 2025 Jun 11;25(1). doi: 10.1515/sjpain-2024-0065. eCollection 2025 Jan 1.

Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson's and Alzheimer's Disease

Blebea NM, Pușcașu C, Hancu G, Stăniguț AM, Chiriță C.

Pharmaceuticals (Basel). 2025 Jun 13;18(6):890. doi: 10.3390/ph18060890.

Neurotoxic effects of aluminum and manganese: From molecular to clinical effects

Zaitseva NV, Zemlyanova МА, Gekht AB, Dedaev SI, Kol'dibekova YV, Peskova ЕV, Stepankov МS, Tinkov AA, Martins AC, Skalny AV, Aschner M.

J Neurol Sci. 2025 Jun 15;473:123480. doi: 10.1016/j.jns.2025.123480. Epub 2025 Apr 10.

Bioanalytical Considerations for Biomarkers of Parkinson's Disease

Huang A, Foti RS, Gunawardana CG, Shen H, Xiao Y.

J Neurochem. 2025 Jun;169(6):e70131. doi: 10.1111/jnc.70131.

Assessing amyloid fibrils and amorphous aggregates: A review

Basha S, Mukunda DC, Pai AR, Mahato KK.

Int J Biol Macromol. 2025 Jun;311(Pt 3):143725. doi: 10.1016/j.ijbiomac.2025.143725. Epub 2025 May 3.

Lipid metabolism in health and disease: Mechanistic and therapeutic insights for Parkinson's disease

Qin B, Fu Y, Raulin AC, Kong S, Li H, Liu J, Liu C, Zhao J.

Chin Med J (Engl). 2025 Jun 20;138(12):1411-1423. doi: 10.1097/CM9.0000000000003627. Epub 2025 May 26.